Sharps Technology Secures Continued Nasdaq Listing with Reverse Split Plan

An update from Sharps Technology, Inc. ( (STSS) ) is now available.

Sharps Technology, Inc. has announced that it will continue to be listed on the Nasdaq stock market following approval from the Nasdaq Hearings Panel, contingent on completing a reverse stock split to address a bid price deficiency. The company’s compliance plan, which includes the reverse split, was presented in August, and the plan is expected to regain compliance within the granted exception period. Sharps Technology specializes in innovative syringe products for the healthcare industry and is expanding its manufacturing capabilities in the U.S.

Learn more about STSS stock on TipRanks’ Stock Analysis page.